0001209191-18-060103.txt : 20181128
0001209191-18-060103.hdr.sgml : 20181128
20181128160326
ACCESSION NUMBER: 0001209191-18-060103
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181127
FILED AS OF DATE: 20181128
DATE AS OF CHANGE: 20181128
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ORDONEZ KATHY
CENTRAL INDEX KEY: 0001222643
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34899
FILM NUMBER: 181205675
MAIL ADDRESS:
STREET 1: 3 GIRALDA FARMS
STREET 2: C/O QUEST DIAGNOSTICS
CITY: MADISON
STATE: NJ
ZIP: 07940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
CENTRAL INDEX KEY: 0001299130
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 161590339
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1305 O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-521-8000
MAIL ADDRESS:
STREET 1: 1305 O'BRIEN DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
FORMER COMPANY:
FORMER CONFORMED NAME: PACIFIC BIOSCIENCES OF CALIFORNIA INC
DATE OF NAME CHANGE: 20050829
FORMER COMPANY:
FORMER CONFORMED NAME: NANOFLUIDICS INC
DATE OF NAME CHANGE: 20040729
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-27
0
0001299130
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
PACB
0001222643
ORDONEZ KATHY
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
1305 O'BRIEN DRIVE
MENLO PARK
CA
94025
1
1
0
0
Chief Commercial Officer
Common Stock
2018-11-27
4
M
0
25000
2.90
A
68750
D
Common Stock
2018-11-27
4
S
0
25000
7.54
D
43750
D
Stock Option (right to buy)
2.90
2018-11-27
4
A
0
25000
0.00
D
2017-12-15
2027-11-15
Common Stock
25000
350000
D
This sale price represents the weighted average sale price of the shares sold ranging from $7.54 to $7.545 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The shares subject to the option will vest in equal monthly installments over a four year period.
/s/ Stephen Moore, Attorney-in-fact for Kathy Ordonez
2018-11-28